Biological evaluation of ent -narciclasine, ent -lycoricidine and certain enantiomerically-related congeners
| dc.contributor.author | Matveenko, Maria | |
| dc.contributor.author | Banwell, Martin | |
| dc.contributor.author | Joffe, Max | |
| dc.contributor.author | Wan, Soosan | |
| dc.contributor.author | Fantino, Emmanuelle | |
| dc.date.accessioned | 2015-12-10T22:30:18Z | |
| dc.date.issued | 2009 | |
| dc.date.updated | 2016-02-24T10:23:01Z | |
| dc.description.abstract | The non-natural enantiomeric forms of narciclasine and lycoricidine ((-)-1 and (-)-2, respectively), as well as congeners 3-6 are available through chemoenzymatic synthesis. Accordingly, they have now been tested for their cytotoxic effects in a 13-member human cancer cell-line panel and found to be only weakly active. In contrast, an authentic sample of the natural enantiomeric form of narciclasine ((+)-1) was found to be highly active in the same screens. | |
| dc.identifier.issn | 1612-1872 | |
| dc.identifier.uri | http://hdl.handle.net/1885/55037 | |
| dc.publisher | Wiley-VCH Verlag GMBH | |
| dc.source | Chemistry & Biodiversity | |
| dc.subject | Keywords: antineoplastic agent; lycoricidine; narciclasine; unclassified drug; antineoplastic activity; article; cancer cell culture; drug cytotoxicity; drug screening; drug synthesis; enantiomer; female; human; human cell; male; Amaryllidaceae Alkaloids; Antineopl | |
| dc.title | Biological evaluation of ent -narciclasine, ent -lycoricidine and certain enantiomerically-related congeners | |
| dc.type | Journal article | |
| local.bibliographicCitation.issue | 5 | |
| local.bibliographicCitation.lastpage | 691 | |
| local.bibliographicCitation.startpage | 685 | |
| local.contributor.affiliation | Matveenko, Maria, College of Physical and Mathematical Sciences, ANU | |
| local.contributor.affiliation | Banwell, Martin, College of Physical and Mathematical Sciences, ANU | |
| local.contributor.affiliation | Joffe, Max, Cytopia Pty Ltd | |
| local.contributor.affiliation | Wan, Soosan, Cytopia Pty Ltd | |
| local.contributor.affiliation | Fantino, Emmanuelle, Cytopia Pty Ltd | |
| local.contributor.authoruid | Matveenko, Maria, u4195285 | |
| local.contributor.authoruid | Banwell, Martin, u9500594 | |
| local.description.embargo | 2037-12-31 | |
| local.description.notes | Imported from ARIES | |
| local.identifier.absfor | 030401 - Biologically Active Molecules | |
| local.identifier.ariespublication | u4005981xPUB317 | |
| local.identifier.citationvolume | 6 | |
| local.identifier.doi | 10.1002/cbdv.200800319 | |
| local.identifier.scopusID | 2-s2.0-67649369572 | |
| local.type.status | Published Version |
Downloads
Original bundle
1 - 1 of 1
Loading...
- Name:
- 01_Matveenko_Biological_evaluation_of__ent_2009.pdf
- Size:
- 257.56 KB
- Format:
- Adobe Portable Document Format